1. Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington;Amiri;J. Subst. Abuse Treat.,2018
2. Spatial access to opioid treatment program and alcohol and cannabis outlets: analysis of missed doses of methadone during the first, second, and third 90 days of treatment;Amiri;Am. J. Drug Alcohol Abuse,2020
3. Access to office-based buprenorphine treatment in areas with high rates of opioid-related mortality: an audit study;Beetham;Ann. Intern. Med.,2019
4. Bouchery, E., Morris, R., Little, J., Examining substance use disorder treatment demand and treatment capacity in a changing health care system: Initial findings report. Washington, DC: U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Disability, Aging, and Long-term Care Policy; 2015. https://aspe.hhs.gov/reports/examining-substance-use-disorder-treatment-demand-provider-capacity-changing-health-care-system.
5. Not at all what I had expected': discontinuing treatment with extended-release naltrexone (XR-NTX): a qualitative study;Brenna;J. Subst. Abuse Treat.,2022